CRYSTAL BOYER: Open Payments
NPI 1780230623 · POTTSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,130 in 118 payments from 19 companies in 2025. Trend: 2023 $56 · 2024 $163 · 2025 $2,130
Food & beverage: $2,130
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $273 |
| Janssen Biotech, Inc. | 9 | $230 |
| Novo Nordisk Inc | 4 | $180 |
| Aimmune Therapeutics, Inc. | 13 | $146 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $144 |
| GENZYME CORPORATION | 3 | $142 |
| Madrigal Pharmaceuticals | 5 | $139 |
| PFIZER INC. | 13 | $138 |
| Ardelyx, Inc. | 5 | $130 |
| Ipsen Biopharmaceuticals, Inc | 5 | $119 |
Products named: TREMFYA, DUPIXENT, Wegovy, XIFAXAN, REZDIFFRA, IBSRELA, ZENPEP, IQIRVO.
Industry payments across PA — which companies pay providers there.
